Tritonix.ai

News / Korea / yonhap_finance

Medytox Shares Surge Over 10% in After-Hours Trading

Health Technology · Biotechnology · yonhap_finance · 2026-09-02

086900

Shares of KOSDAQ-listed Medytox experienced a sharp rally of over 10% during after-hours trading, drawing significant attention from investors.

What Happened

After-Hours Rally: Medytox, a company listed on the KOSDAQ, saw its shares jump by more than 10% during after-hours trading. As of 4:58 PM, the stock was trading at 78,500 won, marking a 10.25% increase from its regular session closing price of 71,200 won.

Increased Volatility: The significant price movement in the after-hours session stands out compared to the regular trading day. This sudden rally reflects heightened investor interest and potential market sentiment shifts regarding the company.

Investor Attention: The unexpected surge has sparked discussions among market participants regarding the potential drivers behind the move. Investors are closely watching to see if this momentum will carry over into the next regular trading session.

Market Outlook: While the after-hours rally has captured market attention, participants are advised to remain cautious due to the typically lower liquidity and higher volatility associated with off-hours trading. Future price action will depend on whether this trend is sustained during normal market hours.

Read original

More in Health Technology

KOSDAQ IR Executive Reported to Authorities for Insider Trading

Health Technology · yonhap_finance · 2026-09-02

A KOSDAQ-listed company's IR executive has been reported to law enforcement for using non-public information regarding new drug development to gain profits.

Apex Medical's Smart Pressure Relief Bed Reduces Nursing Workload by 69% in NTUH Study

Health Technology · cnyes · 2026-09-02

Apex Medical reports that its automated pressure relief bed significantly eases nursing burdens, supporting a positive outlook for the second half of the year.

4106

Handa Pharma Surges Over 6% After Patent Lawsuit Dismissed in US

Health Technology · cnyes · 2026-09-02

Handa Pharma's stock rallied after the original manufacturer dropped a patent infringement lawsuit against its cancer drug HND-039, with expectations of FDA approval this quarter.

6620

Latest in Korea

Kumsung Faces Regulatory Sanctions Over Accounting Irregularities

Process Industries · yonhap_finance · 2026-09-02

South Korean regulators have imposed fines and mandated external auditor oversight on Kumsung following the discovery of falsified sales and financial reporting.

001570

KOSDAQ IR Executive Reported to Authorities for Insider Trading

Health Technology · yonhap_finance · 2026-09-02

A KOSDAQ-listed company's IR executive has been reported to law enforcement for using non-public information regarding new drug development to gain profits.

South Korean Government Bond Yields Surge Amid Rising Oil Prices and Global Rate Hikes

Finance · yonhap_finance · 2026-09-02

South Korean government bond yields climbed across the board as global inflation concerns and geopolitical tensions in the Middle East pushed oil prices higher.

Industry Experts Discuss 'T+1' Settlement Cycle Shift for South Korean Stock Market

Finance · yonhap_finance · 2026-09-02

Market participants agree on the need to shorten the settlement cycle to T+1, but emphasize the importance of infrastructure readiness and sufficient time.